Vivos Therapeutics, Inc. (VVOS) stock
VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.08−0.00 (-3.04%)
Close on Nov 17, 2026Market cap $1.60MP/E –Yield –
Vivos Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Vivos Therapeutics's total debt was $8.14M at Jun 30, 2026. For fiscal 2025 it was $8.82M, up 635.2% from the year before. The highest annual figure on record is $8.82M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.82M | +635.2% |
| FY2024 | Dec 31, 2024 | $1.20M | 0.0% |
| FY2023 | Dec 31, 2023 | $1.20M | -5.1% |
| FY2021 | Dec 31, 2021 | $1.27M | -1.9% |
| FY2020 | Dec 31, 2020 | $1.29M | -65.2% |
| FY2019 | Dec 31, 2019 | $3.71M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.14M | +2.8% |
| Q1 FY2026 | Mar 31, 2026 | $7.72M | +543.1% |
| Q4 FY2025 | Dec 31, 2025 | $8.82M | +635.2% |
| Q3 FY2025 | Sep 30, 2025 | $8.72M | +626.5% |
| Q2 FY2025 | Jun 30, 2025 | $7.92M | +559.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.20M | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.20M | 0.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.20M | -5.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.20M | -5.1% |
| Q3 FY2023 | Sep 30, 2023 | $1.20M | -5.1% |
| Q2 FY2023 | Jun 30, 2023 | $1.20M | -5.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.27M | -1.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.27M | -65.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.27M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.27M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.29M | – |
| Q4 FY2019 | Dec 31, 2019 | $3.71M | – |
See a number that looks wrong?